504 related articles for article (PubMed ID: 21362138)
1. Hyaluronan-CD44 interactions as potential targets for cancer therapy.
Misra S; Heldin P; Hascall VC; Karamanos NK; Skandalis SS; Markwald RR; Ghatak S
FEBS J; 2011 May; 278(9):1429-43. PubMed ID: 21362138
[TBL] [Abstract][Full Text] [Related]
2. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
3. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
Ghatak S; Hascall VC; Markwald RR; Misra S
J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
[TBL] [Abstract][Full Text] [Related]
4. PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow.
Alves CS; Konstantopoulos K
PLoS One; 2012; 7(10):e41472. PubMed ID: 23056168
[TBL] [Abstract][Full Text] [Related]
5. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
6. CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.
Härkönen K; Oikari S; Kyykallio H; Capra J; Hakkola S; Ketola K; Thanigai Arasu U; Daaboul G; Malloy A; Oliveira C; Jokelainen O; Sironen R; Hartikainen JM; Rilla K
Cells; 2019 Mar; 8(3):. PubMed ID: 30909497
[TBL] [Abstract][Full Text] [Related]
7. Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen).
Raman PS; Alves CS; Wirtz D; Konstantopoulos K
Biophys J; 2012 Aug; 103(3):415-423. PubMed ID: 22947857
[TBL] [Abstract][Full Text] [Related]
8. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
[TBL] [Abstract][Full Text] [Related]
9. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes.
Wallach-Dayan SB; Grabovsky V; Moll J; Sleeman J; Herrlich P; Alon R; Naor D
J Cell Sci; 2001 Oct; 114(Pt 19):3463-77. PubMed ID: 11682606
[TBL] [Abstract][Full Text] [Related]
10. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
11. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H
J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression.
Bourguignon LY
Small GTPases; 2012; 3(1):53-9. PubMed ID: 22714418
[TBL] [Abstract][Full Text] [Related]
13. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
14. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
Bourguignon LY; Zhu D; Zhu H
Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
[TBL] [Abstract][Full Text] [Related]
15. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
16. Involvement of hyaluronan and CD44 in cancer and viral infections.
Heldin P; Kolliopoulos C; Lin CY; Heldin CH
Cell Signal; 2020 Jan; 65():109427. PubMed ID: 31654718
[TBL] [Abstract][Full Text] [Related]
17. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
[TBL] [Abstract][Full Text] [Related]
18. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
19. CD44 and hyaluronan binding by human myeloid cells.
Smadja-Joffe F; Legras S; Girard N; Li Y; Delpech B; Bloget F; Morimoto K; Le Bousse-Kerdiles C; Clay D; Jasmin C; Levesque JP
Leuk Lymphoma; 1996 May; 21(5-6):407-20, color plates following 528. PubMed ID: 9172805
[TBL] [Abstract][Full Text] [Related]
20. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]